scispace - formally typeset
H

Heinrich M. Schulte

Researcher at National Institutes of Health

Publications -  66
Citations -  5610

Heinrich M. Schulte is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Corticotropin-releasing hormone & Pituitary gland. The author has an hindex of 37, co-authored 66 publications receiving 5493 citations. Previous affiliations of Heinrich M. Schulte include Boston Children's Hospital & University of Kiel.

Papers
More filters
Journal ArticleDOI

Molecular Determinants of Glucocorticoid Receptor Function and Tissue Sensitivity to Glucocorticoids

TL;DR: This review has summarized the multiple endogenous and exogenous factors that have been shown to be involved in this signaling cascade and, thus, to alter glucocorticoid sensitivity.
Journal ArticleDOI

Dehydroepiandrosterone replacement in women with adrenal insufficiency.

TL;DR: Dehydroepiandrosterone improves well-being and sexuality in women with adrenal insufficiency and significantly improved overall well- being as well as scores for depression and anxiety.
Journal ArticleDOI

The corticotropin-releasing factor stimulation test. An aid in the evaluation of patients with Cushing's syndrome.

TL;DR: Investigation of the effect of exogenous corticotropin-releasing factor on plasma levels of ACTH and cortisol in patients with ACTH-secreting pituitary adenomas and other forms of Cushing's syndrome concludes that stimulation of the pituitaries-adrenal axis with corticotropic factor may be useful in differentiating pituitsary from ectopic causes of Cushed's syndrome.
Journal ArticleDOI

Preoperative lateralization of ACTH-secreting pituitary microadenomas by bilateral and simultaneous inferior petrosal venous sinus sampling.

TL;DR: The utility of selective catheterization of the inferior petrosal sinus for determination of plasma ACTH concentrations in the diagnosis of pituitary-dependent hypercortisolism is established and simultaneous sampling of bilateral venous blood should provide a means of localizing the microadenoma in one side of the pituitaries.
Journal ArticleDOI

Oral Dehydroepiandrosterone for Adrenal Androgen Replacement: Pharmacokinetics and Peripheral Conversion to Androgens and Estrogens in Young Healthy Females after Dexamethasone Suppression

TL;DR: 50 mg DHEA seems to be a suitable replacement dose in females with adrenal insufficiency, and the rapid and lasting conversion to potent androgens demonstrates a potential role of D HEA for androgen replacement in females in general.